Sort
11,323 grants matching “glioblastoma”
Project 1: Modeling tumor evolution in mouse and organoid models
$398,421Raul Rabadan · Columbia University Health Sciences · U54 · FY2017 · CA
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma
$398,398Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma
$398,398Wei Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Inhibition of the ALK Receptor Kinase
$398,357Georgetown University · R01 · FY2004 · CA
Endothelial plasticity in glioma vascularization and therapy resistance
$398,055Yi Fan · University Of Pennsylvania · R01 · FY2021 · NS
Development of Novel CD180-Based Cancer Immunotherapeutics
$398,040Edward A Clark · Abacus Bioscience Inc · R41 · FY2022 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$398,030Arvind P Pathak · Johns Hopkins University · R01 · FY2024 · CA
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$398,001Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$397,908John H Sampson · Duke University · R01 · FY2017 · NS
Myeloid Recruitments and their Role in Brain Tumors
$397,899Dolores Hambardzumyan · University Of Pennsylvania · R01 · FY2025 · NS
Human in Mouse Modeling of HNSCC to Predict Resonse to Therapy
$397,820Wendell G Yarbrough · Vanderbilt University · RC1 · FY2009 · CA
Bimodal EGFR signaling in glioblastoma
$397,700Amyn Habib · Ut Southwestern Medical Center · R01 · FY2024 · NS
Selectivity and Efficacy of CD90-targeted Phase Shift Microbubbles for HIFU-mediated Non-Thermal Ablation of Brain Tumors.
$397,597Emmanuelle Joelle Meuillet · Microvascular Therapeutics, Llc · R43 · FY2022 · CA
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
$397,500Aaron J Johnson · Mayo Clinic Rochester · R56 · FY2016 · NS
Targeting N-linked Glycosylation to Enhance Radiation Therapy
$397,474Joseph N Contessa · Yale University · R01 · FY2014 · CA
Mechanisms of exRNA Trafficking
$397,388Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2014 · CA
Role of the collagen receptor LAIR-1 in glioma progression and the tumor immune microenvironment
$397,315Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Role of the collagen receptor LAIR-1 in glioma progression and the tumor immune microenvironment
$397,315Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Genetic Mouse Models of Glioma
$397,314Luis F Parada · Ut Southwestern Medical Center · R01 · FY2014 · CA
DEVELOPMENT OF MICROFLUIDICS INTEGRATED NANOELECTRONIC SENSORS AS A DIAGNOSTIC TO
$397,311Paul S Mischel · California Institute Of Technology · U54 · FY2009 · CA
Targeting the Vascular System
$397,281Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2015 · CA
Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors
$397,189Hang Chang · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2015 · CA
Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors
$397,105Hang Chang · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2016 · CA
Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors
$397,105Hang Chang · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2017 · CA
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
$397,078Karol Bomsztyk · University Of Washington · U01 · FY2021 · CA